EIF2S2P3

Across TCGA pan-cancer cohorts, EIF2S2P3 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated EIF2S2P3 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher EIF2S2P3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated EIF2S2P3 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.

LUAD, ACC, and BLCA are the cancer types where EIF2S2P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.623	0.740	<.001	82	view →
ACC	OS	Quartile	All	0.363	0.905	<.001	76	view →
BLCA	DFS	Median	All	0.467	0.701	.001	63	view →
KIRP	OS	Quartile	III,IV	0.468	0.854	.003	57	view →
MESO	OS	Tertile	IV	0.161	0.700	.003	41	view →
LGG	DFS	Tertile	All	0.643	0.797	<.001	41	view →
LIHC	OS	Median	II,III,IV	0.474	0.742	.001	36	view →
BRCA	DFS	Tertile	III,IV	0.592	0.372	.005	35	view →
SKCM	OS	Quartile	III,IV	0.798	0.550	<.001	20	view →
CESC	OS	Quartile	IV	0.270	0.822	.007	18	view →
TGCT	DFS	Median	All	0.936	0.727	.001	16	view →
KIRC	DFS	Quartile	All	0.511	0.700	.004	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

EIF2S2P3–LUAD (OS)

Open the LUAD breakdown →